؉ -ATPase is involved in lumenal acidification of the epididymis. This protein is highly expressed in narrow and clear cells where it is located in the apical pole, and it contributes to proton secretion into the lumen. We have previously shown that in rats, epididymal cells rich in H ؉ ATPase appear during postnatal development and reach maximal numbers at 3-4 wk of age. The factors that regulate the appearance of these cells have not been investigated, but androgens, estrogens, or both may be involved. This study examined whether neonatal administration of estrogens ( epididymis, estradiol, male reproductive tract, steroid hormones, testosterone
INTRODUCTION
The major function of the epididymis is to maintain a lumenal fluid environment, which is optimal for the maturation and, in many animals, the storage of spermatozoa [1] . The ability of epididymal epithelial cells to alter the ionic composition of the lumenal fluid has been measured, some of the major transport proteins involved in this process have been identified, and their sites of expression have been characterized [1] [2] [3] [4] [5] [6] [7] . Transepithelial transport of water and various anions and solutes take place in the epididymis [3] . Results from our laboratory indicate that vacuolar-type H ϩ -ATPase is a key player in the establishment of an acidic pH in the epididymal lumen. In vitro studies on isolated rat vas deferens using inhibitors of proton secretion, such as bafilomycin, suggested that H ϩ -ATPase is a major source of acidification [8] . Epididymal cells that contain H ϩ -ATPase also coexpress carbonic anhydrase type 2 (CAII) [9, 10] , suggesting that bicarbonate transport proteins are also important in lumenal acidification. The involvement of bicarbonate transport in the acidification process was confirmed in isolated vas deferens [11] . Epididymal cells rich in H ϩ -ATPase share similar features to type A intercalated cells of the kidney collecting duct, which also express vacuolar-type H ϩ -ATPase and CAII, and they play a major role in urinary acidification [12] . These proton-secreting cells are often referred to as ''mitochondria-rich cells'' [13, 14] .
Previous studies have localized H ϩ -ATPase to specific epithelial cell types in all regions of the epididymis; these are apical (or narrow) cells within the initial segment region, and clear (or light) cells within the caput, corpus, and cauda regions of the epididymis [7, 8] . The timing of postnatal differentiation of narrow and clear cells has been assessed primarily by electron microscopy, and they are fully differentiated around the time of sexual maturation (ϳ42 days) in the rat [15] . Our further studies on postnatal expression of H ϩ -ATPase in the rat epididymis have shown that cells rich in H ϩ -ATPase are not present immediately after birth and that at Postnatal Day 14, cells that express H ϩ -ATPase are still rare in the epididymis, although they are readily detected in the vas deferens [10] . H ϩ -ATPase reaches its peak level of expression in the epididymis at 3-4 wk after birth [10] . The factors that regulate the postnatal maturation of the cell types that express H ϩ -ATPase within the epididymis are not fully understood.
It is well known that testosterone is required in order to stabilize the Wolffian duct prior to its differentiation into the epididymis, vas deferens, and seminal vesicles [16, 17] . Testosterone exerts its effects via activation of the androgen receptor (AR), as does the 5␣-reduced androgen, dihydrotestosterone (DHT). It is less clear whether the metabolites of testosterone, namely, estradiol or the major metabolite of DHT, 5␣-androstane-3␣, 17␤-diol, have any role to play in epididymal differentiation or maturation. Steroid receptors for both androgens and estrogens are present in the epididymis during postnatal development [18] [19] [20] [21] , and we have established that neonatal manipulation of these hor- mones in the rat can result in major changes in the structural differentiation of the epididymis and vas deferens during the peripubertal period [21] ; estrogens or the androgen: estrogen balance appear to be the most important factors in this [20] . These findings raise the question of whether such structural changes are associated with altered expression of epididymal proteins such as H ϩ -ATPase. The present study, therefore, assessed whether neonatal hormonal manipulation alters the subsequent development of cells rich in H ϩ -ATPase during pubertal development. Manipulation of the levels and action of estrogen, androgen, or both were performed neonatally during the period of onset of the expression of H ϩ -ATPase. The consequences of these treatments on the development of H ϩ -ATPase-rich cells were determined in the rat epididymis at Postnatal Day 25, when the number of these cells should be at its peak [10] .
MATERIALS AND METHODS

Animals, Treatments, Sample Collection, and Processing
Wistar rats were bred and maintained in the Medical Research Council animal facility (Edinburgh). All animal studies were performed under license from and according to the legal requirements of the United Kingdom Home Office. Rats were administered one of the following treatments postnatally. In our studies the day of birth was assigned as Day 1. Based on the nomenclature below, the rats treated in a preliminary study (study 1) received either treatment 1, 2, 3, or 5. In a follow-up study (study 2) a cohort of rats was treated with one of the six regimens listed below. The rationale for the TE dose has been fully described elsewhere [20] ; 5. Subcutaneous injection of 10 mg/kg of a long-acting gonadotropinreleasing hormone antagonist (GnRHa; Antarelix, Europeptides, Argenteuil, France) in 5% mannitol administered on Postnatal Days 2 and 5. This regimen has been shown to abolish gonadotropin secretion until Postnatal Days 15-20 [22] and to lower testosterone levels [23] ; 6. Subcutaneous injection of the androgen-receptor antagonist, flutamide (Sigma), administered at a dose of 50 mg/kg in 20 l of corn oil on alternate days from Day 2 through Day 12. These animals were compared with an additional group of control rats.
For all treatments, pups were weaned at 22 days and fed standard rat and mouse breeding diet no. 3 (SDS, Dundee, Scotland). Animals were killed on Day 25 by inhalation of CO 2 , followed by cervical dislocation. The right epididymis from each animal was fixed for ϳ5 h in periodatelysine paraformaldehyde (PLP), which contains 2% paraformaldehyde [24] , and the whole left epididymis was snap-frozen and stored at Ϫ70ЊC prior to protein extraction. In study 2, the right testis was weighed after necropsy and the other reproductive organs were snap-frozen for use in other experiments.
Testosterone Assay
Plasma testosterone levels were measured using an ELISA adapted from an earlier radioimmunoassay method [25] as detailed elsewhere [26] . The limit of detection was ϳ12 pg/ml.
Immunocytochemistry
The PLP-fixed epididymides of control and treated 25-day-old rats were cryoprotected by immersion in 30% sucrose in PBS for at least 4 h. The entire epididymis (head, body, and tail) was then mounted in OTC compound Tissue-Tek (Miles Inc., Elkhart, IN) and frozen at Ϫ29ЊC in a Reichert Frigocut cryostat (Reichert Jung, Derry, NH). Sections were cut at 4 m, picked up onto Superfrost/Plus microscope slides (Fisher Scientific, Pittsburgh, PA), and kept at 4ЊC.
For immunostaining, the sections were hydrated for 10 min in PBS, and antigen retrieval was performed by incubating the slides for 4 min with 1% SDS in PBS. After three washes in PBS for 5 min each, nonspecific staining was blocked by applying to the slides a solution of 1% BSA in PBS/0.02% sodium azide for 15 min. An affinity-purified rabbit primary antibody against the 56-kDa subunit of the vacuolar H ϩ -ATPase was applied to the slides at a concentration of 1:1000 in DAKO diluent (DAKO Corporation, Carpinteria, CA) for 90 min at room temperature. Sections were then washed twice for 5 min each time in PBS containing 2.7% NaCl to reduce nonspecific binding, followed by one wash in normal PBS. For immunofluorescence labeling, a secondary goat anti-rabbit antibody coupled to the fluorophore CY3 (Jackson Immunologicals, West Grove, PA) was applied to the slides at a 1:800 dilution in DAKO diluent for 1 h at room temperature, followed by the same series of washes that were used for the primary antibody. The slides were mounted in Vectashield diluted 1:1 with Tris buffer pH 8.5 (Vector Laboratories, Burlingame, CA).
Control incubations were performed using antibodies that had been preabsorbed with an excess of the immunizing peptide (11 amino acids that correspond to the C-terminus of the 56 kDa, B1 subunit of the H ϩ -ATPase) prior to the first incubation step.
Quantification of H
ϩ -ATPase Immunoexpression Study 1. Black-and-white photographs were taken of the whole epididymis of each animal. The number of H ϩ -ATPase positive cells on each photograph was counted and the basement membrane of the associated tubule was drawn around using a Wacom graphics tablet (Vancouver, WA). The mean number of immunopositive cells per millimeter of epididymal tubular basal membrane was calculated for each animal.
Study 2. Sections were examined using a Nikon Eclipse 800 epifluorescence microscope (Micro Video Instruments Inc., Avon, MA). Black-andwhite images were obtained using a Hamamatsu Orca CCD digital camera (Micro Video Instruments Inc.) and IP lab Spectrum software (Scanalytics, Vienna, VA). The images were taken using a 20ϫ objective.
Cells with positive fluorescence staining for vacuolar H ϩ -ATPase in the epididymides were counted on digital images while they appeared on the computer screen. The basal perimeter of the epididymal tubules that were analyzed was measured using IP lab Spectrum software. The final number of positive cells per millimeter in the perimeter of the basal membrane of the tubule was calculated for each image in Microsoft Excel. The number of rats analyzed in each cohort is listed in Table 1 .
Protein Extraction
Whole epididymides from each treatment group were powdered in a porcelain mortar with a pestle under liquid nitrogen. The powder was scraped into an Eppendorf tube and stored on dry ice. Protein was extracted by the addition of 200 l of cold extraction buffer (10 mM Hepes pH 7.9, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 0.5 mM PMSF, and 1ϫ Complete protease inhibitor cocktail [Roche, Lewes, U.K.]). The tissue remained on ice for 15 min before adding 25 l of 10% Nonident P-40 (Sigma). The tube was then vortexed three times for 10 sec. The tube was then centrifuged at 12 000 ϫ g for 1 min at 4ЊC, the supernatant was decanted, and 100-g aliquots were frozen on dry ice before being stored at Ϫ40ЊC. 
Western Blot Analysis
The expression of H ϩ -ATPase and ␤-actin protein were determined in 25-day-old rat epididymal protein extracts using Western blotting. Protein markers (Bio-Rad Laboratories, U.K.) and protein samples (from all treatment groups) were separated by SDS-PAGE using gradient gels (4%-20%; Novex precast gels, Invitrogen,). The gels were run at 110 V for ϳ2 h before blotting onto a polyvinylidene difluoride membrane (Immobilon-P; Millipore, Watford, U.K.) at 33 V for 180 min using Tris/Gly transfer buffer (Invitrogen). The membranes were blocked for 1 h in 5% milk/ TBS, 50 mM Tris-HCl, and 150 mM NaCl. The membranes were washed thoroughly in TBST (TBS containing 0.05% Tween-20; Sigma) before the primary antibody was added. An affinity-purified chicken antiserum against the 31-kDa subunit of the H ϩ -ATPase was added at a dilution of 1:1000 (TBS containing 0.02% sodium azide) and incubated at 4ЊC overnight. Alternatively, a commercially available ␤-actin monoclonal antiserum (Sigma) was added to the membrane at a dilution of 1:8000 and incubated overnight. The membranes were washed at least four times for 15 min in TBST. The second antibody was then added to the membrane and incubated for 1 h (for H ϩ -ATPase, we used a rabbit anti-chicken immunoglobulin G conjugated to horseradish peroxidase [Sigma] ; for ␤-actin, we used a goat anti-mouse immunoglobulin G conjugated to peroxidase) before being thoroughly washed in TBST. The H ϩ -ATPase protein was detected using enhanced chemiluminescence (Amersham, Buckinghamshire, U.K.) according to the manufacturer's instructions. The membranes were then exposed to Hyperfilm-LS (Kodak) until optimal development of the signal was detected. The film was scanned (Snapscan-e-40; AGFA, Middlesex, U.K.) using Scanwise software (AGFA). The image was then mounted in Photoshop 5.5 (Adobe, San Jose, CA).
Statistical Analysis
Data are expressed as means Ϯ SEM. One-way ANOVA was performed followed by the Tukey test. Statistical significance was conducted at a level of confidence of P Ͻ 0.05.
RESULTS
The results of study 1 are presented first, followed by those obtained in study 2. ,but this decrease failed to reach statistical significance. This group had three animals, two of which showed a major decrease, and a third that showed little difference from control values. This variation in GnRHa response was one reason why a larger follow-up study was performed.
Study 2
The treatments performed in study 1 were repeated and, in addition, a cohort of rats was also treated neonatally with DES ϩ TE to determine whether the administration of testosterone could prevent the negative effects of DES observed in study 1. Similarly, to determine whether androgen action via the AR is important in establishing or maintaining cells that are rich in H ϩ -ATPase, a cohort of rats was treated neonatally with the AR antagonist flutamide.
Testis Weight
Administration of GnRHa, EE, DES, or DES ϩ TE induced similar effects on testis weight at 25 days of age, causing Ͼ85% reduction in weight (Table 1) . These findings demonstrate the effectiveness of the respective treatments in retarding testicular development [20] . In contrast, neonatal administration of flutamide was without significant effect on testicular weight in this particular study.
Specificity of the H ϩ -ATPase Antibody
To confirm specificity of the H ϩ -ATPase antibody, immunofluorescence experiments were conducted using antibodies that had been preabsorbed with an excess of the immunizing peptide prior to the first incubation step. As shown in Figure 2 , the immunoreactivity was completely abolished by preabsorption of the antibodies (compare Fig.  2, A and B) , indicating specificity of the staining.
Plasma Testosterone Levels in Neonatally Treated Rats
Testosterone levels in 25-day-old rats were significantly reduced in all cohorts treated neonatally with GnRHa, DES, or EE as shown in Figure 3A . Plasma testosterone levels were assessed in 18-day-old rats after neonatal flutamide treatment (Fig. 3B) . This graph illustrates the variable effect of flutamide treatment on testosterone levels, but overall, there was no significant increase in levels after flutamide treatment.
Quantification of H ϩ -ATPase-Rich Cells in Control and Neonatally Treated Rats
The epididymides of control rats all exhibited a large subpopulation of H ϩ -ATPase immunopositive cells. As demonstrated in study 1, the immunofluorescence was largely present in the apical pole (Fig. 4A) . The morphology of the positive cells appeared similar throughout the epididymis, with tall columnar epithelial cells being evident in all regions. Panels B and C in Figure 4 illustrate cauda
FIG. 4. Immunoexpression of H ϩ -ATPase in Day 25 rat cauda epididymidis from a control rat (A) and rats treated neonatally with either GnRHa (B), DES (C), or DES ϩ TE (D). Note the reduction in H
ϩ -ATPase immunostaining similar to that shown in Figure 1 after DES and GnRHa treatment, but also note the similarity in the intensity and number of immunopositive cells in control animals and those treated with DES ϩ TE. Bar ϭ 40 m.
FIG. 5. Quantification of the number of H
ϩ -ATPase-positive cells per millimeter of epididymal tubule basal membrane at Day 25 in control rats and in rats treated neonatally with either GnRHa, DES, EE, or DES ϩ TE. **P Ͻ 0.01, ***P Ͻ 0.001 compared with control. Data are means Ϯ SEM for n ϭ 4-8 (as stated in Table 1 ).
epididymides from Day 25 rats after neonatal treatment with GnRHa or DES, respectively (EE not shown), and demonstrate broadly similar reductions in the number of H ϩ -ATPase-positive cells to those illustrated in Figure 1 . The epididymides of animals treated with GnRHa and DES showed retarded development, as evidenced by smaller epididymal lumens when compared with control rats or those treated with DES ϩ TE (Fig. 4, A and D, respectively) . Coadministration of DES ϩ TE resulted in the maintenance of epididymal epithelial H ϩ -ATPase immunoexpression at levels similar to controls. Morphologically, the epididymal epithelium of the animals treated with DES ϩ TE appeared broadly similar to that in controls. However, despite the maintenance of H ϩ -ATPase levels, the testes weight of these animals were similar to those measured in rats treated with DES alone or with GnRHa ( Table 1) . The number of H ϩ -ATPase-positive cells per millimeter of basal membrane was quantified in each group (Fig. 5) . Rats treated neonatally with either GnRHa or DES exhibited ϳ65% fewer H ϩ -ATPase positive cells, whereas treatment with EE caused a reduction of 45% (Fig. 5) . Animals coadministered DES ϩ TE neonatally had H ϩ -ATPase positive cells that were comparable in number to the control cohort at Day 25 (50.3 Ϯ 13.8 vs. 49.6 Ϯ 9.8 immunopositive cells per millimeter of epididymal basal membrane, respectively).
A separate cohort of rats was treated with vehicle or the androgen receptor antagonist flutamide (Fig. 6, A and B,  respectively) . Similar to GnRHa, DES, and EE treatments, administration of flutamide induced a reduction in the number of H ϩ -ATPase positive cells, although this effect was less marked than in animals treated with DES alone or with GnRHa. The tubule lumen was smaller in the treated group, indicating that flutamide treatment also retarded epididymal lumen development. These observations are in accordance with published data [20] . Quantification analysis showed that the rats treated neonatally with flutamide exhibited a 34% reduction in the mean number of H ϩ -ATPase positive cells per millimeter of epididymal basal membrane (Fig. 7) compared with their controls.
Western Blot Analysis of H ϩ -ATPase Protein Levels
To confirm the changes in the expression of H ϩ -ATPase that was detected by immunofluorescence after neonatal hormone treatments, Western blot analysis was performed (Fig. 8) . In homogenates from control epididymides, the affinity-purified antibody revealed a strong band at around 31 kDa and an additional band at around 60 kDa, as we have described previously [27] (Fig. 8, A and B) . Treatments with GnRHa, DES, or EE induced a marked reduc- tion in the intensity of these bands, whereas coadministration of DES ϩ TE prevented the reduction in H ϩ -ATPase expression that occurred after DES treatment alone (Fig.  8A) . Similarly, Western blot analysis confirmed that neonatal treatment with flutamide induced a reduction in H ϩ -ATPase protein levels in comparison to control levels (Fig.  8B) . To demonstrate equal protein loading in each sample, a Western blot against ␤-actin was also performed (Fig. 8,  C and D) .
DISCUSSION
Vacuolar H
ϩ -ATPase is involved in the process of lumenal acidification in the male reproductive tract of both rats and humans [7, 8, 12, 27] . The acidic lumenal environment is believed to play a role in maintaining and storing sperm in an immotile state prior to ejaculation [17, 28, 29] . We have previously shown that H ϩ -ATPase is expressed in a subpopulation of epididymal epithelial cells, the narrow cells in the initial segments, and clear cells in the remainder of the epididymis [7, 8, 10, 12] , and that these cells are present as early as 2 wk after birth [10] . At this time point, a large number of H ϩ ATPase-rich cells were observed in the vas deferens, whereas only a few positive cells were detected in the epididymis, suggesting that the ability to secrete protons may begin in the vas deferens and progress back toward the epididymis during postnatal development. The peak time of H ϩ -ATPase expression in the epididymis occurs at around Postnatal Day 25 [10] . Therefore, both the onset and peak expression of the H ϩ -ATPase occur at ages when the testicular production of testosterone is relatively low [28, 30] , suggesting that the expression of H ϩ -ATPase might be regulated by factors other than androgens, or in addition to them. Alternatively, the low levels of androgens present in prenatal and prepubertal male rats might be sufficient to trigger the development of H ϩ -ATPase-rich cells. In addition, the epididymis acquires detectable activity of the enzyme ⌬ 4 -5␣-reductase [30] , which converts testosterone to the more potent DHT at 21 days after birth, and it remains possible that significant levels of local DHT might be present and contribute to the initiation of the H ϩ ATPase-rich cell phenotype during early postnatal development.
Previous data in the literature suggested that narrow and clear cells (also called apical mitochondria-rich cells) were under the control of estrogens and not androgens [14] . Another study showed that lumenal acidification in the rat epididymis is under androgen control [31] . The current study was, therefore, designed to test whether neonatal manipu- lation of sex steroid levels affected the development of epididymal H ϩ -ATPase-rich cells. Our data suggest that administration of estrogen (DES or EE), GnRHa, or flutamide can suppress the postnatal development of H ϩ -ATPase-rich cells. We also observed a significant reduction in testis weights and in plasma testosterone levels in all treatment groups, except for animals treated with flutamide (DES ϩ TE was not assessed for plasma testosterone levels). These treatments (GnRHa, DES, EE, and DES ϩ TE) probably retarded testicular growth via suppression of the hypothalamo-pituitary axis and subsequent suppression of gonadotropin secretion, because we have shown that all of these treatments significantly reduce FSH levels ( [22, 32, 33] and unpublished data). This is supported by the similarity in the degree of testis weight reduction observed between GnRHa and DES/ EE treatments, as has also been reported in other studies [20, 34] , and by the observation that coadministration of GnRHa and DES has no greater effect on testis weight than either treatment alone (unpublished data). The comparable levels of the reduction in the number of H ϩ -ATPase-rich cells observed in animals treated with DES and GnRHa are suggestive of a common mechanism in altering the development of this cell phenotype. This most likely centers on interference with androgen production, action, or both, because both GnRHa and DES treatments suppress blood levels of testosterone [23] , and DES (but not GnRHa) treatment causes a major reduction in expression of the androgen receptor protein in the epididymis and vas deferens [20, 35] . The possibility that the DES effects observed in the present study were at least partially attributed to lower levels of androgens was confirmed by the observation that neonatal coadministration of testosterone with DES was able to restore epididymal expression of H ϩ -ATPase. In addition, H ϩ -ATPase expression in the epididymis was reduced by neonatal flutamide administration. Because flutamide induced no change in testis weight or plasma testosterone levels, indicating no suppression of the hypothalamo-pituitary axis, the reduction in the number of H ϩ ATPase-rich cells by this agent is presumably due to direct inhibition of epididymal androgen action. Thus, the most unifying explanation for our findings is that altered expression of H ϩ -ATPase in the Day 25 epididymis results directly from insufficient androgen action during neonatal development. However, our results do not exclude the possibility that the effects observed in animals treated neonatally with estrogens, GnRHa, or flutamide are secondary to a general retardation of development of the epididymis, as indicated by the immature morphological appearance of the epididymis under these treatments, which has been described in other studies [20] .
We have shown previously that some other morphological effects on the reproductive tract that were observed after neonatal DES administration, such as rete testis distension, loss of aquaporin-1 expression in the efferent ducts, and malformation of the epididymis/vas deferens, were not altered after GnRHa administration [36] , suggesting an estrogenic action of DES in addition to androgen suppression [20] . In addition, previous reports have suggested that estrogens might be involved in the maturation of some epididymal cell types that express H ϩ -ATPase [10, 14] . Epididymal epithelial cells are structurally undifferentiated in all regions of the epididymis at Postnatal Day 21 [15] , and some H ϩ -ATPase expressing cell types (i.e., caput and corpus epididymal clear cells) are not fully differentiated until Day 49 despite being exposed to high testosterone levels, which is consistent with a role for other factors in their maturation. Given that the postnatal epididymis contains receptors for estrogen receptor ␤ (ER␤) [21] , and that the major circulating steroid during postnatal development is 3␣-diol [37, 38] , a putative ligand for ER␤, an argument can be proposed in favor of a role for estrogens in the development of H ϩ ATPase-rich cells. Recent evidence suggests that 3␣-diol is a ligand for ERs (preferentially ER␤) and that it acts to regulate AR levels in the rat prostate [39] . Whether or not 3␣-diol regulates AR levels in any other regions of the male reproductive tract has not been investigated, but because one of the major effects of neonatal DES administration is the virtual abolition of AR protein expression in the epididymis [20] , the potential involvement of 3␣-diol is a possibility. Studies of the male rat anterior pituitary have shown that the conversion of DHT to 3␣-diol is reversible and that 3␣-hydroxysteroid dehydrogenase (3␣-HSD) can convert 3␣-diol back into DHT [40] . 3␣-HSD is expressed in neonatal epididymides and may catalyze the local conversion of 3␣-diol from the circulation into DHT, thus promoting the development of H ϩ -ATPase-rich cells. It is possible that this metabolite is capable of acting as a potent androgen via conversion to DHT by 3␣-HSD or as an estrogenic ligand with ER␣ or ER␤ [39] . Because 3␣-HSD, ARs, and ERs are all present in the pubertal epididymis, it is not possible to determine whether 3␣-diol acts in one or all of these roles. The potential dual role of this metabolite reinforces how intimately the actions of androgens and estrogens may be linked. The data presented in our study demonstrate that DES can reduce H ϩ -ATPase expression but to the same H ϩ -ATPase MODULATION IN POSTNATAL RAT EPIDIDYMIS level as neonatal treatment with GnRHa. So, whereas our findings do not exclude direct estrogenic effects on the epididymis, they imply that this role is secondary to, and can be overcome by androgens. The change in development of cells rich in H ϩ -ATPase induced by neonatal administration of steroids emphasizes the importance of the steroid hormone environment for maintaining the normal timing and intensity of expression of genes such as H ϩ -ATPase and that altering the steroid environment can repress or retard their expression.
In summary, this study examined whether androgens, estrogens, or both are involved in the development of cells that are rich in H ϩ -ATPase. Our data show that treatment with either a potent GnRHa or estrogen (DES or EE) is sufficient to significantly reduce the expression of this protein. It is possible that these compounds induce this reduction via suppressing the hypothalamo-pituitary axis with consequent reduction in androgen levels [41, 42] and subsequent loss of androgen receptor protein expression or action in the reproductive tract [20, 35] . Because cells rich in H ϩ -ATPase were not lost in animals treated neonatally with DES ϩ TE, this suggests that androgens are capable of preventing some of the effects induced by DES. This role for androgens is supported by the reduction in the number of H ϩ ATPase-rich cells observed in rats treated with the androgen receptor antagonist flutamide during postnatal development. Additional support is provided by the previous observation that flutamide treatment of the adult rat epididymis induces an increase in lumenal pH, consistent with androgen action being responsible for maintaining a low pH within the epididymis [31] . Our data suggest that normal serum testosterone levels and functional epididymal ARs are required for normal developmental expression of H ϩ -ATPase-rich cells in the epididymis.
